XML 33 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating Activities      
Net Income $ 727 $ 905 $ 661
Net Income 720 911 668
Adjustments to reconcile Net Income to net cash from operating activities:      
Depreciation and amortization 852 1,145 1,094
Nuclear fuel amortization 46 48 38
Allowance for equity funds used during construction (21) (21) (15)
Deferred income taxes 237 356 164
Equity earnings of equity method investees (66) (48) (59)
Dividends from equity method investees 64 55 61
Asset (gains) losses and impairments, net 107 (4) (8)
Changes in assets and liabilities:      
Accounts receivable, net 259 48 (154)
Inventories 1 (177) 123
Accounts payable (158) 128 14
Accrued pension liability (147) 627 (644)
Accrued postretirement liability (287) 165 (526)
Derivative assets and liabilities 47 (199) 107
Regulatory assets and liabilities 85 (1,177) 1,269
Other current and noncurrent assets and liabilities 172 (18) 22
Net cash from operating activities 1,911 1,839 2,154
Investing Activities      
Plant and equipment expenditures — utility (1,817) (1,784) (1,534)
Plant and equipment expenditures — non-utility (203) (265) (342)
Acquisition (241) 0 0
Proceeds from sale of assets 16 45 36
Restricted cash for debt redemption, principally Securitization, net 97 3 (1)
Proceeds from sale of nuclear decommissioning trust fund assets 885 1,146 1,118
Investment in nuclear decommissioning trust funds (898) (1,156) (1,134)
Distributions from equity method investees 19 13 8
Contributions to equity method investees (98) (42) (21)
Other 36 (20) (36)
Net cash used for investing activities (2,204) (2,060) (1,906)
Financing Activities      
Issuance of long-term debt, net of issuance costs 956 1,736 1,234
Redemption of long-term debt (286) (1,237) (961)
Short-term borrowings, net 101 267 (109)
Issuance of common stock 9 0 39
Repurchase of common stock 0 (52) 0
Dividends on common stock (501) (470) (445)
Other 3 (27) (19)
Net cash from (used for) financing activities 282 217 (261)
Net Decrease in Cash and Cash Equivalents (11) (4) (13)
Cash and Cash Equivalents at Beginning of Period 48 52 65
Cash and Cash Equivalents at End of Period 37 48 52
Supplemental disclosure of cash information      
Cash paid (received) for: Interest (net of interest capitalized) 428 415 418
Cash paid (received) for: Income taxes 14 (35) 121
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Plant and equipment expenditures in accounts payable 207 212 329
DTE Electric      
Operating Activities      
Net Income 544 532 487
Adjustments to reconcile Net Income to net cash from operating activities:      
Depreciation and amortization 633 927 896
Nuclear fuel amortization 46 48 38
Allowance for equity funds used during construction (20) (21) (14)
Deferred income taxes 320 297 108
Asset (gains) losses and impairments, net 0 (1) (3)
Changes in assets and liabilities:      
Accounts receivable, net 33 33 (30)
Inventories (22) (97) 36
Prepaid postretirement benefit costs — affiliates (24) 0 0
Accounts payable (46) 11 (23)
Regulatory assets and liabilities 65 (926) 1,029
Accrued pension liability — affiliates (224) 495 (663)
Accrued postretirement liability — affiliates (213) 151 (417)
Other current and noncurrent assets and liabilities 58 (65) 44
Net cash from operating activities 1,150 1,384 1,488
Investing Activities      
Restricted cash for debt redemption, principally Securitization, net 96 4 2
Proceeds from sale of nuclear decommissioning trust fund assets 885 1,146 1,118
Investment in nuclear decommissioning trust funds (898) (1,156) (1,134)
Other 6 (14) (33)
Plant and equipment expenditures (1,545) (1,561) (1,325)
Acquisitions (310) 0 0
Notes receivable — affiliate 8 192 (200)
Transfer of Rabbi Trust assets to affiliate 137 0 0
Net cash used for investing activities (1,621) (1,389) (1,572)
Financing Activities      
Issuance of long-term debt, net of issuance costs 495 942 768
Redemption of long-term debt (135) (837) (590)
Dividends on common stock (395) (370) (342)
Other (7) (9) (3)
Capital contribution by parent company 300 190 400
Short-term borrowings, net — other 222 50 (130)
Short-term borrowings, net — affiliate (8) 26 (22)
Net cash from (used for) financing activities 472 (8) 81
Net Decrease in Cash and Cash Equivalents 1 (13) (3)
Cash and Cash Equivalents at Beginning of Period 14 27 30
Cash and Cash Equivalents at End of Period 15 14 27
Supplemental disclosure of cash information      
Cash paid (received) for: Interest (net of interest capitalized) 244 240 256
Cash paid (received) for: Income taxes (53) 4 183
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]      
Plant and equipment expenditures in accounts payable $ 150 $ 162 $ 231